|

Capecitabine plus temozolamide Clinical Trials

1 actively recruiting trial

Also known as: CAPE-TEM

Pipeline

Phase 3: 1

Top Sponsors

  • Tata Memorial Hospital1

Indications

  • Neuroendocrine Gastroenteropancreatic Tumour1
  • Neuroendocrine Tumor GEP Grade 1-31
  • Neuroendocrine Neoplasia's (NENs)1
  • Cancer1

Other1 trial

PRRT Versus PRRT Plus Chemotherapy in GEP NET (PReCedeNT Trial)
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.